Differences in DNA methylation of HAMP in blood cells predicts the development of type 2 diabetes

OBJECTIVES: Better disease management can be achieved with earlier detection through robust, sensitive, and easily accessible biomarkers. The aim of the current study was to identify novel epigenetic biomarkers determining the risk of type 2 diabetes (T2D). METHODS: Livers of 10-week-old female New...

Descripción completa

Detalles Bibliográficos
Autores principales: Ouni, Meriem, Eichelmann, Fabian, Jähnert, Markus, Krause, Christin, Saussenthaler, Sophie, Ott, Christiane, Gottmann, Pascal, Speckmann, Thilo, Huypens, Peter, Wolter, Stefan, Mann, Oliver, De Angelis, Martin Hrabé, Beckers, Johannes, Kirchner, Henriette, Schulze, Matthias B., Schürmann, Annette
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10422014/
https://www.ncbi.nlm.nih.gov/pubmed/37429525
http://dx.doi.org/10.1016/j.molmet.2023.101774

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10422014/
https://www.ncbi.nlm.nih.gov/pubmed/37429525
http://dx.doi.org/10.1016/j.molmet.2023.101774

Ejemplares similares